A
ACAD ACADIA Pharmaceuticals Inc., San Diego, CA. +103% on 21.5 mill shares: ACP-103 antipsychotic efficacy. 3/20/2007
ADLR Adolor Corporation, Exton, PA. -59% on 28 million shares: Entereg/constipation trial halted. 4/10/2007AGIX AtheroGenics, Inc., Alpharetta, GA. -61% on 22 million shares: Failed Phase III Test. 3/20/2007
ALGN Align Technology, Inc., Santa Clara, CA. +33% on 10.3 million shares: posts Q1 profit. 4/26/2007 AMKR Amkor Technology, Chandler, AZ. +12% afterhours on 250k shares: good conference call. 11/08/2006AVNR AVANIR Pharmaceuticals, Aliso Viejo, CA. +309% on 86 million shares: Diabetes drug positive results. 4/18/2007
